CRBP Earnings Date: Nov 11, 2026 (Estimated) — Corbus Pharmaceuticals Holdings, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is CRBP's next earnings date?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.27 on revenue of $1.7M.
How did CRBP do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Corbus Pharmaceuticals Holdings, Inc. posted EPS of -$1.81 versus the -$1.26 estimate, a miss of 44.8%. Revenue was $0 against a $1.1M estimate. The stock's 1-day post-earnings move was +1.8%.
How much does CRBP stock move after earnings?
CRBP beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.4% (up or down) in the day after earnings.
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -1.26 | -1.81 | -44.80% | $0 | ❌ Miss | +1.78% | +1.99% | +19.75% |
| 2026-05-12 | Q1 2026 | -1.23 | -1.23 | +0.00% | $0 | ➖ Inline | +3.53% | -9.87% | -30.25% |
| 2026-03-09 | Q4 2025 | -1.66 | -1.25 | +24.70% | $0 | ✅ Beat | +19.23% | +17.48% | +21.22% |
| 2025-11-12 | Q3 2025 | -1.74 | -1.90 | -9.20% | $0 | ❌ Miss | +7.39% | +15.26% | -7.10% |
| 2025-08-05 | Q2 2025 | -1.42 | -1.44 | -1.41% | $0 | ❌ Miss | -4.71% | -7.17% | +5.46% |
| 2025-03-11 | Q4 2024 | -1.22 | -0.78 | +36.07% | $0 | ✅ Beat | +1.33% | +2.50% | -20.62% |
| 2024-11-07 | Q3 2024 | -0.95 | -1.15 | -21.05% | $0 | ❌ Miss | +1.40% | -5.24% | -17.71% |
| 2024-08-06 | Q2 2024 | -1.26 | -0.90 | +28.57% | $0 | ✅ Beat | -3.80% | -4.76% | +0.64% |
Showing last 8 quarters.